The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Co-administration of opioids and cannabinoids can enhance pain relief even when administered on different days. Repeated systemic administration of morphine has been shown to enhance the antinociceptive effect of tetrahydrocannbinol (THC) administered 12 hours later, and repeated microinjection of the cannabinoid receptor agonist HU-210 into the ventrolateral periaqueductal gray (PAG) has been shown to enhance the antinociceptive effect of morphine administered one day later. The primary objective of the present study was to test the hypotheses that this cannabinoid/opioid interaction is bidirectional. Experiment 1 showed that microinjection of morphine into the ventrolateral PAG of male Sprague-Dawley rats twice daily for 2 days enhanced the antinociceptive effect of HU-210 measured one day later. In Experiment 2, twice daily systemic injections of THC enhanced the antinociceptive effect of morphine administered one day later. These results complement the previously mentioned studies by showing that morphine and cannabinoid interactions are bidirectional and that the ventrolateral PAG plays an important role in this effect. In contrast to the PAG, repeated administration of HU-210 or the cannabinoid receptor agonist, WIN 55,212-2, into the RVM had a neurotoxic effect. Rats became ill following repeated cannabinoid administration whether given alone or with morphine. Presumably, this neurotoxic effect was caused by the high cannabinoid concentration following RVM microinjection because rats did not become ill following repeated systemic THC administration. These findings indicate that alternating opioid and cannabinoid treatment could produce a longer lasting and more potent analgesia than either compound given alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An analgesia circuit activated by cannabinoids
Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L. (1998) · Nature · doi:10.1038/26481 · Cited by 411 · cited 2×
“This antinociception appears to be mediated by inhibition of GABAergic neurons (Meng et al., 1998; Vaughan et al., 1999), as has been reported for morphine antinociception (Heinricher and Tortorici, 1994; Pan et al.”
Cannabinoid–Opioid Interaction in Chronic Pain
Abrams, D. I., Couey, P., Shade, S. B., Kelly, M. E., & Benowitz, N. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.188 · Cited by 319 · cited 1×
“Recent clinical data suggest that combined opioid/cannabinoid therapy is a viable option for efficacious pain relief, particularly in patients already undergoing opioid therapy (Abrams et al., 2011).”
Synergistic interactions between cannabinoid and opioid analgesics
Cichewicz, D. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.038 · Cited by 305 · cited 1×
“In addition to the synergy produced by simultaneous administration of an opioid and cannabinoid (Cichewicz, 2004; Cichewicz and McCarthy, 2003; Cox et al., 2007), the antinociceptive effects of cannabinoids are enhanced even when administered after morphine antinociception has dissipated (Williams…”
Frank, B., Serpell, M. G., Hughes, J., Matthews, J. N. S., & Kapur, D. (2008) · BMJ · doi:10.1136/bmj.39429.619653.80 · Cited by 207 · cited 2×
“Although the antinociceptive effects of cannabinoids are relatively mild (Frank et al., 2008; Hohmann et al., 1999), pretreatment with a non-antinociceptive dose of tetrahydrocannabinol (THC) has been shown to cause up to a 22-fold enhancement of morphine potency (Smith et al.”
Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration
Cichewicz, D. L., & McCarthy, E. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045575 · Cited by 154 · cited 2×
“In addition to the synergy produced by simultaneous administration of an opioid and cannabinoid (Cichewicz, 2004; Cichewicz and McCarthy, 2003; Cox et al., 2007), the antinociceptive effects of cannabinoids are enhanced even when administered after morphine antinociception has dissipated (Williams…”
The Enhancement of Morphine Antinociception in Mice by Î9-Tetrahydrocannabinol
Smith, F. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00012-4 · Cited by 146 · cited 3×
“This enhanced antinociception occurs following oral, dermal, intrathecal, intracranial ventricular and systemic injections (Cichewicz et al., 1999, 2005; Cox et al., 2007; Finn et al., 2004; Smith et al., 1998; Welch and Stevens, 1992;Welch et al., 1995).”
Cichewicz, D. L., & Welch, S. P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046870 · Cited by 110 · cited 3×
“Mice made tolerant to morphine showed enhanced antinociception to oral THC when assessed 12 h after the last morphine injection (Cichewicz and Welch, 2003; Rubino et al., 1997).”
Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine
Roberts, J. D., Gennings, C., & Shih, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.036 · Cited by 103 · cited 2×
“Isobolographic analysis reveals that the antinociception produced by co-administration of opioids and cannabinoids is synergistic (Cichewicz andMcCarthy, 2003; Roberts et al., 2006; Tham et al., 2005).”
Tham, S. M., Angus, J. A., Tudor, E. M., & Wright, C. E. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706045 · Cited by 98
Wilson-Poe, A. R., Morgan, M. M., Aicher, S. A., & Hegarty, D. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.038 · Cited by 79 · cited 1×
“…our recent anatomical analysis showing that CB1 receptors are found on approximately one third of the PAG neurons with mu-opioid receptor labeling (Wilson-Poe et al., 2012) suggests that cannabinoid/opioid interactions are mediated by adaptations to intracellular signaling pathways in neurons…”
Self-citation
Cited by
Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301
Wilkerson, J. L., Ghosh, S., Mustafa, M., Abdullah, R. A., Niphakis, M. J., Cabrera, R., Maldonado, R. L., Cravatt, B. F., & Lichtman, A. H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.015 · Cited by 78
Auh, Q.-S., Chun, Y. H., Melemedjian, O. K., Zhang, Y., & Ro, J. Y. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.07.009 · Cited by 14
Metadata
- Authors
- Wilson-Poe, A. R., Pocius, E., Herschbach, M., & Morgan, M. M.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 103
- Issue
- 3
- Pages
- 444-449
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2009887688
- Cited by
- 54
- References
- 13
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids. https://app.cochat.ai/papers/10.1016/j.pbb.2012.10.002
- The paper
- Wilson-Poe, A. R., Pocius, E., Herschbach, M., & Morgan, M. M. (2013). The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2012.10.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.